Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study
Conclusions:
In a cohort of NAFLD-HCC patients, statin use was protective against HCC, while hypertension conferred an increased risk. Visceral adiposity at baseline was not a risk factor, but was higher in male patients before HCC development, declining in the majority by HCC diagnosis.
Source: Journal of Clinical Gastroenterology - Category: Gastroenterology Tags: LIVER, PANCREAS & BILIARY TRACT: Original Articles Source Type: research
More News: Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | CT Scan | Fatty Liver Disease (FLD) | Gastroenterology | Hepatocellular Carcinoma | Hypertension | Liver | Liver Cancer | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Pancreas | Pancreatic Cancer | PET Scan | Statin Therapy | Study | Urology & Nephrology